Effects of salbutamol on rat diaphragm contractility

被引:15
作者
VanDerHeijden, HFM
VanBalkom, RHH
Folgering, HTM
VanHerwaarden, CLA
Dekhuijzen, PNR
机构
[1] Department of Pulmonary Diseases, University Hospital Nijmegen
[2] Dept. of Pulmonary Diseases, Univ. Hospital Nijmegen, 6500 HB Nijmegen
关键词
contractile properties; dose response; beta-adrenergic agonists; respiratory muscles;
D O I
10.1152/jappl.1996.81.3.1103
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
The aim of this study was to investigate I) the effects and time course of single doses of salbutamol on isometric contractile properties of isolated rat diaphragm strips and 2) whether these effects were caused by a direct effect on the muscle. Two experiments were performed. In one, salbutamol was administered subcutaneously in doses of 12.5, 25, 50, or 100 mu g/kg (25 and 50 mu g/kg sc resulted in serum concentrations of similar to 9 and similar to 15 mu g/l, respectively, 0.5 h after injection) and in vitro contractile properties were determined 0.5, 1, 2, or 4 h after administration; in the other, salbutamol was added to the tissue bath in a concentration of less than or equal to 2, similar to 10, similar to 20, and similar to 80 mu g/l. Twitch force, maximal tetanic force, and twitch force-to-tetanic force ratio all increased in a dose-dependent way in both experiments. The increases in force generation were slightly higher after subcutaneous administration. Force-frequency curves were shifted upward in both experiments. No significant effects of time of salbutamol administration were found, but the increase in force generation was most pronounced within 2 h after subcutaneous administration. In conclusion, in vitro force generation can be improved by low concentrations of salbutamol. The slightly higher increases in force generation after subcutaneous administration suggest that in vivo salbutamol may have additional positive inotropic actions on diaphragm contractility besides a direct beta(2)-adrenergic effect on the muscle itself.
引用
收藏
页码:1103 / 1110
页数:8
相关论文
共 37 条
[21]   METABOLIC STUDIES OF SALBUTAMOL-H-3 - A NEW BRONCHODILATOR, IN RAT, RABBIT, DOG AND MAN [J].
MARTIN, LE ;
HOBSON, JC ;
PAGE, JA ;
HARRISON, C .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1971, 14 (02) :183-&
[22]   BETA-ADRENERGIC-RECEPTOR DISTRIBUTION AMONG MUSCLE-FIBER TYPES AND RESISTANCE ARTERIOLES OF WHITE, RED, AND INTERMEDIATE SKELETAL-MUSCLE [J].
MARTIN, WH ;
MURPHREE, SS ;
SAFFITZ, JE .
CIRCULATION RESEARCH, 1989, 64 (06) :1096-1105
[23]   SALBUTAMOL, A BETA-2-ADRENOCEPTOR AGONIST, INCREASES SKELETAL-MUSCLE STRENGTH IN YOUNG MEN [J].
MARTINEAU, L ;
HORAN, MA ;
ROTHWELL, NJ ;
LITTLE, RA .
CLINICAL SCIENCE, 1992, 83 (05) :615-621
[24]   PHARMACOKINETICS OF INTRAVENOUS AND ORAL SALBUTAMOL AND ITS SULFATE CONJUGATE [J].
MORGAN, DJ ;
PAULL, JD ;
RICHMOND, BH ;
WILSONEVERED, E ;
ZICCONE, SP .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 22 (05) :587-593
[25]   EFFECT OF A BETA-2-AGONIST (BROXATEROL) ON RESPIRATORY MUSCLE STRENGTH AND ENDURANCE IN PATIENTS WITH COPD WITH IRREVERSIBLE AIRWAY-OBSTRUCTION [J].
NAVA, S ;
CROTTI, P ;
GURRIERI, G ;
FRACCHIA, C ;
RAMPULLA, C .
CHEST, 1992, 101 (01) :133-140
[26]   SINGLE DOSING COMPARISON OF THE RELATIVE CARDIAC BETA-1/BETA-2 ACTIVITY OF INHALED FENOTEROL AND SALBUTAMOL IN NORMAL SUBJECTS [J].
NEWNHAM, DM ;
WHEELDON, NM ;
LIPWORTH, BJ ;
MCDEVITT, DG .
THORAX, 1993, 48 (06) :656-658
[27]   INVESTIGATIONS INTO FACTORS DETERMINING THE DURATION OF ACTION OF THE BETA-2-ADRENOCEPTOR AGONIST, SALMETEROL [J].
NIALS, AT ;
SUMNER, MJ ;
JOHNSON, M ;
COLEMAN, RA .
BRITISH JOURNAL OF PHARMACOLOGY, 1993, 108 (02) :507-515
[28]  
NORUSIS MJ, 1992, SPSS PC PLUS 5 0 BAS
[29]  
NUMATA H, 1993, RESP PHYSIOL, V94, P25
[30]   CHANGES IN TISSUE BLOOD-FLOW AND BETA-RECEPTOR DENSITY OF SKELETAL-MUSCLE IN RATS TREATED WITH THE BETA-2-ADRENOCEPTOR AGONIST CLENBUTEROL [J].
ROTHWELL, NJ ;
STOCK, MJ ;
SUDERA, DK .
BRITISH JOURNAL OF PHARMACOLOGY, 1987, 90 (03) :601-607